Yasin Orhan Erkuş

Yasin Orhan Erkuş

Auto-generated profile, based on publicly available information

Yasin Orhan Erkuş

Ankara Bilkent City Hospital General Surgery Clinic Ankara Türkiye

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 October 2025 in Anz Journal of Surgery
Verified
Journal Article
Closed access
SYSerhan Yilmaz
Serhan Yilmaz
CCCanbert Celik
Canbert Celik
YEYasin Orhan Erkus
Yasin Orhan Erkus
ASAli Sapmaz
Ali Sapmaz
MAMahmut Ozan Aydın
Mahmut Ozan Aydın
ESErkan Somuncu
Erkan Somuncu

3 November 2025
Verified
Book
Open access
PDF file
SŞSunay Şengezer
Sunay Şengezer
İAİsmail Aydın
İsmail Aydın
HCHatice Coşkun
Hatice Coşkun
GGGökmen Güzel
Gökmen Güzel
MÇMuhammet Ömer Çetinkaya
Muhammet Ömer Çetinkaya
TSTuran Eray Seven
Turan Eray Seven

3 November 2025
Verified
Book Chapter
Open access
PDF file
YEYasin Orhan Erkuş
Yasin Orhan Erkuş
Divertiküler hastalık özellikle gelişmiş toplumlarda en sık karşılaşılan, hem ayaktan tedavi hem de yatış gerektiren benign kolorektal hastalıklardan biridir. Divertiküler hastalık

29 June 2026 in Acta Medica
Verified
Journal Article
Open access
YEYasin Orhan Erkuş
Yasin Orhan Erkuş
SYSerhan Yılmaz
Serhan Yılmaz
CÇCanbert Çelik
Canbert Çelik
ASAli Sapmaz
Ali Sapmaz
OÖOnur Öztel
Onur Öztel
ZMZeyneddin Ali Muhammed
Zeyneddin Ali Muhammed
Objective: This study aimed to evaluate the predictive value of the hemoglobin, albumin, lymphocyte, and platelet (HALP) score for lymph node metastasis (LNM) in patients with resectable gastric cancer and to investigate the relationship between hematological markers and LNM. Materials and Methods: Patients who underwent surgery for gastric adenocarcinoma between 2020 and 2024 were retrospectively analyzed. Demographic data, comorbidities, and laboratory parameters were recorded, and the HALP score, neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and platelet-to-neutrophil ratio (PNR) were calculated. Tumor stage, nodal stage, and pathological features were reviewed. The optimal HALP cutoff value was determined by receiver operating characteristic (ROC) curve analysis. Variables significant in univariate analysis were included in multivariate logistic regression to identify independent risk factors for LNM. Results: A total of 238 patients were included, with a mean age of 65.5 ± 11.4 years; 70.2% were male. The mean number of dissected lymph nodes was 26.0 ± 10.6, and the mean number of metastatic nodes was 6.2 ± 9.0. Perineural invasion (PNI) and lymphovascular invasion (LVI) were observed in 66.8% and 71.0% of patients, respectively. LNM was present in 159 patients (66.8%). In univariate analysis, a low HALP score, advanced invasion depth, and the presence of PNI and LVI were significantly associated with LNM (p < 0.005). ROC analysis identified an optimal HALP cutoff value of 17 (AUC = 0.581, p = 0.041). In multivariate analysis, invasion depth (p = 0.001), PNI (p = 0.008), and LVI (p < 0.001) were independent predictors of LNM, whereas the HALP score was not (p = 0.221). Conclusion: In resectable gastric cancer, a low HALP score was associated with lymph node metastasis but was not confirmed as an independent predictive factor. As a composite parameter reflecting systemic inflammation and immune–nutritional status, the HALP score may indicate tumor aggressiveness and poor prognosis. Preoperative recognition of low HALP(<17) scores may help identify patients requiring closer monitoring for LNM risk.